BNP PARIBAS FINANCIAL MARKETS - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,990,944
+68.2%
236,355
+302.9%
0.01%
+71.4%
Q2 2023$5,344,017
-30.5%
58,661
-49.7%
0.01%
-36.4%
Q1 2023$7,692,915
+311.0%
116,630
+222.2%
0.01%
+266.7%
Q4 2022$1,871,695
-100.0%
36,196
-68.6%
0.00%
-76.9%
Q3 2022$7,879,225,000
+768.3%
115,362
+474.9%
0.01%
+1200.0%
Q2 2022$907,475,000
+181.2%
20,068
+216.0%
0.00%
Q1 2022$322,694,000
-54.3%
6,351
-57.5%
0.00%
-100.0%
Q4 2021$706,221,000
+87.3%
14,937
+30.6%
0.00%0.0%
Q3 2021$377,062,000
+159.1%
11,440
+396.7%
0.00%
Q2 2021$145,550,000
-54.8%
2,303
-69.3%
0.00%
Q1 2021$321,911,000
-30.4%
7,502
-7.2%
0.00%
-100.0%
Q4 2020$462,348,000
+8.3%
8,083
-42.9%
0.00%0.0%
Q3 2020$426,996,000
+79.2%
14,153
+94.0%
0.00%
Q2 2020$238,222,000
-70.4%
7,294
-75.7%
0.00%
-100.0%
Q1 2020$803,512,000
-49.3%
29,993
-42.0%
0.00%
-33.3%
Q4 2019$1,584,064,000
+796.8%
51,733
+605.6%
0.00%
Q3 2019$176,628,000
+72.6%
7,332
+81.6%
0.00%
Q2 2019$102,323,000
-30.2%
4,038
-46.3%
0.00%
Q1 2019$146,620,000
+366450.0%
7,519
+250533.3%
0.00%
Q4 2018$40,000
-99.8%
3
-99.7%
0.00%
Q3 2018$21,016,000
-19.2%
1,1820.0%0.00%
Q2 2018$26,004,000
-39.8%
1,182
-39.5%
0.00%
Q1 2018$43,225,000
-11.5%
1,955
-13.1%
0.00%
Q4 2017$48,825,0002,2500.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders